Adell Harriman & Carpenter’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Adell Harriman & Carpenter’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-56,204	Closed	-$191K	–	153
2018 Q3	$191K	Sell	56,204 -1,000	-2%	-$3.6K	0.04%	142
2018 Q2	$215K	Hold	57,204	–	–	0.04%	144
2018 Q1	$234K	Hold	57,204	–	–	0.05%	138
2017 Q4	$266K	Sell	57,204 -3,000	-5%	-$16.5K	0.06%	130
2017 Q3	$427K	Buy	+60,204	New	+$433K	0.09%	106

Adell Harriman & Carpenter's KERX Position: Q4 2018 in Review

Adell Harriman & Carpenter sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 56,204 shares — an estimated $191K sold.

Adell Harriman & Carpenter first reported a position in KERX in Q3 2017 and held it in 5 quarters. The position peaked at $427K in Q3 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Adell Harriman & Carpenter reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Adell Harriman & Carpenter sold 56,204 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $191K.
Adell Harriman & Carpenter first reported a position in Keryx Biopharmaceuticals Inc in Q3 2017 and held it in 5 quarters.
Adell Harriman & Carpenter's Keryx Biopharmaceuticals Inc position peaked at $427K in Q3 2017.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Adell Harriman & Carpenter's 13F filing for Q4 2018, filed 8 Feb 2019.